Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor‐necrosis‐factor‐α‐mediated pathway
Authors:
- 1 April 1994
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 221 (1) , 335-341
Abstract
Lipid A is the active principle of lipopolysaccharide (LPS). Synthetic lipid A analogues with monosaccharide backbones, GLA‐60, GLA‐69 and GLA‐58, which exhibit potent, weak and scarce agonistic activities of LPS, respectively, induced tolerance against LPS lethality in galactosamine‐(GalN)‐sensitized mice while none of them were pyrogenic in rabbits. The tolerance‐inducing mechanisms were investigated focusing on the regulation of tumor‐necrosis‐factor‐α(TNF‐α)‐mediated lethal pathway of LPS. Induction of serum TNF‐α in LPS‐challenged mice was suppressed by prior administration of these analogues as well as LPS. Prior treatment of murine macrophages with the substances suppressed LPS‐stimulated TNF‐α production in the culture supernatant and TNF‐α mRNA expression in the cells as well. Lethal toxicity to TNF‐α in GalN‐sensitized mice was effectively suppressed by prior treatment with LPS, GLA‐60 and GLA‐69 but not by GLA‐58. This protective effect was suggested to be mediated by endogenous TNF‐α, which was induced by prior treatment with the effective substances, because either neutralization of endogenously induced TNF‐α activity with an antibody or deletion of its induction by using LPS‐resistant C3H/HeJ mice reduced the protective effect, and a detectable amount of TNF‐α was produced by stimulating macrophages with the effective substances but not with GLA‐58. These results indicated that multiple regulation steps (one is prior to and the others are following TNF‐α production) are participating in the tolerance induction by LPS and some lipid A analogues and that GLA‐58 is a characteristic compound which induces the tolerance by only blocking the step prior to TNF‐α production.Keywords
This publication has 35 references indexed in Scilit:
- Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activityAntiviral Research, 1990
- Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in derivativesInternational Journal of Immunopharmacology, 1989
- Structural Requirements of Lipid a for Endotoxicity and Other Biological ActivitiesCRC Critical Reviews in Microbiology, 1989
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.Journal of Experimental Medicine, 1987
- Synthetic and natural Escherichia coli free lipid A express identical endotoxic activitiesEuropean Journal of Biochemistry, 1985
- B cell activation and adjuvant activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid AEuropean Journal of Immunology, 1985
- Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid AFEBS Letters, 1984
- Interferon‐inducing, pyrogenic and proclotting enzyme of horseshoe crab activation activities of chemically synthesized lipid A analoguesEuropean Journal of Biochemistry, 1983
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931